94 related articles for article (PubMed ID: 15233254)
21. Quality Assurance and Quality Control, Part 2.
Akers MJ
Int J Pharm Compd; 2015; 19(3):215-21. PubMed ID: 26714362
[TBL] [Abstract][Full Text] [Related]
22. [Preliminary results of microbiologic studies of the processing of contaminated plastics (recycling)].
Agthe O; Flechsig R; Hajifarajollah M; Ihnen D; Paszella H
Dtsch Tierarztl Wochenschr; 1995 Feb; 102(2):101-2. PubMed ID: 7600939
[TBL] [Abstract][Full Text] [Related]
23. Inhibiting the transport of hazardous spores using polymer-based solutions.
Krauter PA; Hoffman DM; Vu AK; Keating GA; Zalk DM
J Occup Environ Hyg; 2007 Nov; 4(11):821-30. PubMed ID: 17763073
[TBL] [Abstract][Full Text] [Related]
24. [LAL test used for detection of undesirable biologically active substances in biopreparations].
Aleksandrowicz J; Fiejka M; Kudelski Z; Marciniak-Rusek A; Paśś-Dziegielewska L
Med Dosw Mikrobiol; 1996; 48(3-4):215-21. PubMed ID: 9182145
[TBL] [Abstract][Full Text] [Related]
25. Contamination Control.
Akers MJ
Int J Pharm Compd; 2015; 19(3):232-8. PubMed ID: 26714364
[TBL] [Abstract][Full Text] [Related]
26. Differentiation between endotoxin and non-endotoxin pyrogens in human albumin solutions using an ex vivo whole blood culture assay.
Pool EJ; Johaar G; James S; Petersen I; Bouic P
J Immunoassay; 1999; 20(1-2):79-89. PubMed ID: 10225516
[TBL] [Abstract][Full Text] [Related]
27. Microbiological performance of a robotic system for aseptic compounding of cytostatic drugs.
Geersing TH; Franssen EJF; Pilesi F; Crul M
Eur J Pharm Sci; 2019 Mar; 130():181-185. PubMed ID: 30710619
[TBL] [Abstract][Full Text] [Related]
28. Design, development and qualification of a microbiological challenge facility to assess the effectiveness of BFS aseptic processing.
Leo F; Poisson P; Sinclair CS; Tallentire A
PDA J Pharm Sci Technol; 2005; 59(1):33-48. PubMed ID: 15796134
[TBL] [Abstract][Full Text] [Related]
29. Analysis of broth-cultured Bacillus atrophaeus and Bacillus cereus spores.
Buhr TL; McPherson DC; Gutting BW
J Appl Microbiol; 2008 Nov; 105(5):1604-13. PubMed ID: 19146496
[TBL] [Abstract][Full Text] [Related]
30. Inactivation of Bacillus endospores in envelopes by electron beam irradiation.
Helfinstine SL; Vargas-Aburto C; Uribe RM; Woolverton CJ
Appl Environ Microbiol; 2005 Nov; 71(11):7029-32. PubMed ID: 16269738
[TBL] [Abstract][Full Text] [Related]
31. Pyrogenic reactions and hemorrhage associated with intrinsic exposure to endotoxin-contaminated intravenous solutions.
Daufenbach LZ; Alves WA; de Azevedo JB; Arduino MJ; Forster TS; Carmo EH; Hatch DL
Infect Control Hosp Epidemiol; 2006 Jul; 27(7):735-41. PubMed ID: 16807850
[TBL] [Abstract][Full Text] [Related]
32. [LAL (Limulus Amoebocyte Lysate) test as applied to the safety evaluation of biological preparations].
Aleksandrowicz J; Kudelski Z
Rocz Panstw Zakl Hig; 1997; 48(3):275-82. PubMed ID: 9432705
[TBL] [Abstract][Full Text] [Related]
33. Addressing endotoxin issues in bioengineered heparin.
Suwan J; Torelli A; Onishi A; Dordick JS; Linhardt RJ
Biotechnol Appl Biochem; 2012; 59(6):420-8. PubMed ID: 23586950
[TBL] [Abstract][Full Text] [Related]
34. QMix® irrigant reduces lipopolysacharide (LPS) levels in an in vitro model.
Gründling GL; Melo TA; Montagner F; Scarparo RK; Vier-Pelisser FV
J Appl Oral Sci; 2015; 23(4):431-5. PubMed ID: 26398517
[TBL] [Abstract][Full Text] [Related]
35. Influence of high voltage atmospheric cold plasma process parameters and role of relative humidity on inactivation of Bacillus atrophaeus spores inside a sealed package.
Patil S; Moiseev T; Misra NN; Cullen PJ; Mosnier JP; Keener KM; Bourke P
J Hosp Infect; 2014 Nov; 88(3):162-9. PubMed ID: 25308932
[TBL] [Abstract][Full Text] [Related]
36. Detection of bacterial endotoxin in antitumor agents.
Siegel SE; Nachum R; Leimbrock S; Karon M
Cancer Treat Rep; 1976 Jan; 60(1):9-15. PubMed ID: 793713
[TBL] [Abstract][Full Text] [Related]
37. Collaborative study of a control standard endotoxin using the Limulus amebocyte (gel-clot) test.
Adner N; Flink O; Nystrand R; Pihl B; Vegis P
J Parenter Sci Technol; 1991; 45(2):88-93. PubMed ID: 2051262
[TBL] [Abstract][Full Text] [Related]
38. Remediating office environments of spore-forming bacteria.
Johnson L; Smith ML; Begin M; Fraser B; Miller JD
J Occup Environ Hyg; 2010 Oct; 7(10):585-92. PubMed ID: 20737349
[TBL] [Abstract][Full Text] [Related]
39. Wet and dry density of Bacillus anthracis and other Bacillus species.
Carrera M; Zandomeni RO; Sagripanti JL
J Appl Microbiol; 2008 Jul; 105(1):68-77. PubMed ID: 18298528
[TBL] [Abstract][Full Text] [Related]
40. Establishing benchmark rates of microbial and bacterial endotoxin contamination for radiopharmaceuticals compounded in commercial nuclear pharmacy settings.
Weatherman KD; Augustine S; Christoff J; Galbraith W
Int J Pharm Compd; 2013; 17(2):168-74. PubMed ID: 23696179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
